In a mindblowing undercover journalistic investigation by Project Veritas, a Pfizer scientist divulged that people who have contracted COVID-19 and then got well naturally are more protected from the virus than individuals who were administered by the vaccine their company manufactures.
Nick Karl, an experienced biochemist who specializes in the fields of pharmaceutical, diagnostics, and the healthcare industry, shared that people who’ve had COVID-19 develop antibodies that protect them from multiple pieces of the virus simultaneously.
Karl explained that individuals given the Pfizer vaccine only develop one type of protective protein designed to attack a single, particular part of the virus that is pretty much a hit-or-miss situation. He also explained further that the vaccine is intended only to protect a vaccinated person from the “outside portion” of the virus and not the actual virus itself.
Remarkably, Nick Karl is not just the only scientist from Pfizer that disclosed this rather shocking piece of information. Senior associate scientist Chris Croce and scientist Rahul Khandke echoed the same sentiments when asked how natural immunity is superior to getting jabbed with the vaccine.
Natural Immune Response is Better than the COVID-19 Vaccine
“You’re protected most likely for longer since there was a natural response,” Croce shared when asked about the level of protection a person gets after previously contracting COVID-19. He added that this protection is probably even more compared to getting the Pfizer vaccine.
“We’re like bred and taught to be like ‘vaccine is safer than actually getting COVID,’” Khandke related, regarding the company’s objective to keep this under wraps. “And that’s like, honestly, we had to do so many seminars like you have no idea. We have to sit there like for hours and listen to like ‘you cannot talk about this’…it’s not in public.”
It’s noteworthy, though, that Croce still recommended getting the vaccine even after getting COVID. However, he pointed out that getting the shot is only needed when a person’s immunity “starts to wane.” When asked if a person who got COVID earlier is well-protected against the virus, Croce said yes. However, he also stressed that this protection is “probably more” than having the vaccine.
Moreover, Croce explained that the recent surge in people requiring hospital care is not caused by the Delta variant of the virus but by the waning of their antibodies sometime after receiving the vaccine. “So they’re still protected but not have 95 percent efficacy,” he pointed out. The level of protection once the antibodies wane is at about 70 percent, Croce stressed.
Shady Means to Make the Unvaccinated Get the Jabs
“They’re trying to keep track of everyone that’s been vaccinated versus the census of how many people are actually reported,” Croce said. “So I mean they’re trying to get their numbers, but still you shouldn’t have to show anything, which is basically, in my opinion, a violation of HIPAA (or the Health Insurance Portability and Accountability Act).”
“No one has the right to ask you if you’ve been vaccinated,” Croce emphasized. “It’s an invasion of privacy. I don’t agree with it.”
Karl disclosed that the protocols set up by cities and similar places aim to force unvaccinated individuals to get the COVID-19 shots. “For instance, the city needs like vax cards and everything,” he explained. “It’s just like about making it so inconvenient for, like, unvaccinated people to the point where they’re just like f**kit, I’ll get it. You know?”
When asked what he meant about that statement, Karl explained that “if you are restricting people that are unvaccinated from doing anything and then, like, vaccinated people are allowed to do anything they want. Eventually, they’re just going to be like, f**k, let me just get vaccinated.”
Monoclonal Antibodies Set Aside for Greed
Croce revealed that monoclonal antibodies had been pushed aside for financial gain not just by Pfizer but by all pharmaceutical companies manufacturing the COVID-19 vaccine.
The monoclonal antibody (mAb) therapy, also referred to as the monoclonal antibody infusion treatment, is one alternative COVID-19 treatment that clones a unique white blood cell. Apart from lessening symptom severity and reducing viral loads, this type of therapy aims to prevent hospitalizations due to the virus.
Croce disclosed that the main reason the research and development of monoclonal antibodies have been pushed to the side is money. “It’s disgusting,” he shared.
“I mean, I still feel like I work for an evil corporation because it comes down to profits in the end, and I mean I’m here to help people and not to make millions and millions of dollars,” the senior associate scientist added. “Basically, our organization is run on COVID money now.” Croce also pointed out that Pfizer netted over $15 billion in 2020.
The Adverse Side Effects of the Pfizer COVID-19 Vaccine are Real
Croce said that there is a risk of developing myocarditis and similar heart issues after being administered with the vaccine and more so for younger people. When asked why this is so, he replied that “this is what they are looking into right now.”
“So, yeah, we’re doing, we just sent, like 3,000 patients’ samples to get tested for like elevated troponin levels (levels to detect heart attack) to see if it’s vaccine-based.” He also openly stressed that if the problem is with the vaccine, “that might pull something from the market.”
When asked why this is something hush-hush when it is supposed to be shared with the millions and millions of people who may experience the adverse side effects after getting the vaccine, this is what Croce had to say: “There’s ears and eyes everywhere…at Pfizer, in the building. So you don’t talk about anything that can possibly implicate you or, like, Big Pharma. Even if you shut the door to the office, it’s kind of like, who’s listening?”
